98%
921
2 minutes
20
Late-onset sepsis (LOS) and necrotizing enterocolitis (NEC) are major causes of neonatal morbidity and mortality. In this prospective, case-control study, we evaluated the metabolic profile of neonates with LOS and NEC. Blood samples were collected from 15 septic neonates and 17 neonates with NEC at the clinical suspicion of the specific diseases. Sixteen gestational and postnatal age-matched neonates without sepsis/NEC served as controls. Serum metabolic profiles were assessed using liquid chromatography-quadrupole time-of-flight mass spectrometry. Metabolomic analysis revealed significant differences in the metabolic profile of neonates with LOS or NEC compared to controls. More specifically, a number of molecules possibly identified as phosphatidylcholines or lysophosphatidylcholines were found to be significantly reduced both in neonates with LOS and those with NEC compared to controls. Additionally, L-carnitine could efficiently discriminate NEC cases from controls. The results of the current study suggest that certain phospholipids and their derivatives could possibly be used as biomarkers for the early detection of LOS and NEC.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505627 | PMC |
http://dx.doi.org/10.3390/jcm11185270 | DOI Listing |
World J Pediatr Surg
August 2025
Lawrence D Longo MD center for perinatal biology, Loma Linda University, Loma Linda, California, USA.
Background: Necrotizing enterocolitis (NEC) is associated with increased neurodevelopmental impairment. Gut-brain interactions through the brainstem may be central to NEC-related microglia-driven neuroinflammation. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) has intestinal protective properties and is a potential therapy for NEC.
View Article and Find Full Text PDFChildren (Basel)
July 2025
Division of Neonatology, St. Paul's Hospital Millennium Medical College, Addis Ababa 1165, Ethiopia.
We sought to address ongoing gaps in understanding the relationship between first-week percent maximal weight loss (MWL) and average first-week total fluid intake (TFI), enteral intake, and parenteral intake among premature newborns with adverse in-hospital outcomes born in low- and middle-income countries (LMICs). We evaluated newborns born <34 weeks gestation or <1500 g who survived at least 7 days at the St. Paul's Hospital Millennium Medical College (SPHMMC) neonatal intensive care unit in Ethiopia.
View Article and Find Full Text PDFEur J Med Res
July 2025
Department of Pediatrics, The First Hospital Affiliated to Army Medical University, No. 30, Gaotanyan Street, Chongqing, 400038, China.
Background: Necrotizing enterocolitis (NEC), a devastating gastrointestinal disease in preterm infants, is strongly linked to sepsis, and 34-57% of NEC cases develop post-sepsis. However, the risk factors for sepsis-associated NEC are still unclear. Therefore, this study aimed to identify predictive factors associated with the occurrence of NEC in premature infants with late-onset sepsis (LOS) and establish a nomogram for early NEC prediction.
View Article and Find Full Text PDFTransl Pediatr
May 2025
Neonatal Medical Center, Children's Hospital of Fudan University/National Children's Medical Center/National Health Commission Key Laboratory of Neonatal Diseases, Shanghai, China.
Background: Very low birth weight infants (VLBWI) are vulnerable to serious complications. We aim to describe the short-term outcomes of VLBWI in a single center during 2013-2023, providing the basis for clinical disease management.
Methods: A retrospective study of VLBWI admitted to a tertiary neonatal intensive care unit (NICU) between 1 January 2013 and 31 December 2023 was conducted to analyze trends of mortality and major morbidities over the 11-year period.
Nutrients
May 2025
Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.
: Sepsis remains a significant cause of morbidity and mortality in preterm and low birth weight (LBW) neonates, especially in low- and middle-income countries (LMICs). Lactoferrin, a glycoprotein present in breast milk with antimicrobial activity, is a low-cost, readily available, and promising intervention currently under investigation. The available literature presents conflicting results on the impact of lactoferrin on the risk of late-onset sepsis (LOS).
View Article and Find Full Text PDF